Please login to the form below

Not currently logged in

Pemphis vulgaris

This page shows the latest Pemphis vulgaris news and features for those working in and with pharma, biotech and healthcare.

GSK unit takes new ofatumumab formulation into phase III

GSK unit takes new ofatumumab formulation into phase III

The trial in patients with pemphigus vulgaris, a serious condition in which patients develop painful blisters in the mouth and on the skin that can become infected. ... At the moment the standard treatment for pemphigus vulgaris - which affects around

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...